SCHEMBL7218022

SCHEMBL7218022

CCCOCCOc1cccc(Oc2ccc3c(c2)C=C(C(=O)OC)CCS3(=O)=O)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.38
ACACA Q13085 3/20 0.38
TSHR P16473 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPT P10636 2/20 0.35
LMNA P02545 2/20 0.35
TLR8 Q9NR97 1/20 0.34
RAB9A P51151 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
FABP1 P07148 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221094 0.94 ACACB (0.42) ACACBACACAALDH1A1KDM4EMAPT
SCHEMBL7216131 0.94 MAPT (0.36) ACACBACACAKDM4EMAPTLMNA
SCHEMBL7215993 0.91 KMT2A (0.39) ACACBACACAALDH1A1KDM4EMAPT
SCHEMBL7216635 0.88 LTA4H (0.39) ACACBACACATSHRALDH1A1KDM4E
SCHEMBL7216023 0.88 L3MBTL1 (0.34) TSHRALDH1A1KDM4EMAPTLMNA
SCHEMBL7215817 0.87 NPC1 (0.38) ALDH1A1KDM4EMAPTLMNARAB9A
SCHEMBL7222381 0.87 GAA (0.33) KDM4EMAPTLMNAGAAKMT2A
SCHEMBL7975157 0.86 RARB (0.40) KDM4EMAPTLMNARAB9A
SCHEMBL7215727 0.85 KMT2A (0.44) ACACBACACAALDH1A1KDM4ELMNA
SCHEMBL7218151 0.84 PPARD (0.34) TSHRALDH1A1KDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed